07th November, 2024
Solutions to simplify, enhance and streamline radiology workflows
image credit- shutterstock
Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD® Centargo CT Injection System, an innovative multi-patient injector that drives workflow efficiency with design features that integrate with Bayer’s portfolio of products, especially in high-volume CT suites. Bayer’s MEDRAD® Centargo CT Injection System delivers value for radiology departments as the US faces a shortage of radiology technologists coupled with a rising demand for medical imaging.
MEDRAD® Centargo CT Injection System reduces patient set-up time, streamlines workflows and incorporates innovative technology
Bayer’s technology advancements and innovative design address the issue of rising demand for medical imaging, amidst the shortage of radiology technologists across the US while incorporating more automation and workflow efficiencies. The MEDRAD® Centargo CT Injection System was designed with two check valves in the patient line to mitigate cross-contamination and inlet and outlet air detection with air removal technology within the day set. The MEDRAD® Centargo CT Injection System enables radiology technologists to focus more on patient care and reduces process and administrative burdens for healthcare providers, specifically in high throughput settings. By integrating with Bayer’s portfolio of imaging and workflow solutions, healthcare providers can optimize contrast-usage and enable connectivity to the modality worklist and scanner.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer